about
Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal UrineRepetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma.Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens."Cheek-to-cheek" urinary proteome profiling via combinatorial peptide ligand libraries: A novel, unexpected elution system.GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.Combinatorial ligand libraries as a two-dimensional method for proteome analysis.Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionNovel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.From hundreds to thousands: Widening the normal human Urinome (1).Widening and diversifying the proteome capture by combinatorial peptide ligand libraries via Alcian Blue dye binding.From hundreds to thousands: Widening the normal human UrinomeFasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models.Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancerIL-27 induces the expression of IDO and PD-L1 in human cancer cells.The oxido-redox potential of albumin methodological approach and relevance to human diseases.2D-electrophoresis and the urine proteome map: where do we stand?Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications.In vivo characterization of renal auto-antigens involved in human auto-immune diseases: the case of membranous glomerulonephritis.Urinary proteome in a snapshot: normal urine and glomerulonephritis.Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.Human urinary exosome proteome unveils its aerobic respiratory ability.Urine proteome analysis in Dent's disease shows high selective changes potentially involved in chronic renal damage.The human urinary exosome as a potential metabolic effector cargo.Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease.Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory-autoimmunity connection.Myelin proteomics: the past, the unexpected and the future.IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation.Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis.Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells.Determination of the oxido-redox status of plasma albumin in hemodialysis patients.Metallothionein-I-II expression in young and adult bovine pineal gland.PROTEOME OF BOVINE MITOCHONDRIA AND ROD OUTER SEGMENT DISKS: COMMONALITIES AND DIFFERENCES.Metabolic Signature of Microvesicles from Umbilical Cord Mesenchymal Stem Cells of Preterm and Term Infants.Functional expression of oxidative phosphorylation proteins in the rod outer segment disc.
P50
Q26753163-CB55584B-FB59-4373-8379-97FD269554A3Q33258651-922F8296-809F-443C-A0AB-05D85C0A812DQ33314116-FBAEA5F7-0E0D-4B29-8610-6250CFA40365Q33530824-F76EED08-37C2-44CD-8DA0-DAA79695A86AQ33922405-E5C4674D-6D40-427B-8365-AAD33D1C5963Q34044233-65C69914-A63E-4DD5-8197-50F54C01A208Q34087961-EA576787-6919-4270-8BB5-D9BF45EA7ACEQ34564455-F13BEEEB-8BF7-414E-9E5E-2F3DE07921DAQ34751431-6EE6EE1B-80FE-484D-A176-1703110000CEQ34999444-9D70C2C9-F808-4B30-B619-001B1275631BQ35049970-A8C3EE0F-BB54-4742-A92D-740C4B34E8A8Q35225054-692E21F6-EB7B-4C41-A6F4-CA09666D947BQ35598053-929C0241-783F-46D0-B383-050CAFCCC7D6Q35718785-771A799A-DAB3-4E53-939B-3B9B53C9B467Q35828442-176000D3-A271-4BBE-893B-F510C07671B1Q36500309-EDA8C7BB-01CA-4F70-9DD8-976F4BB00810Q36685395-074AAD86-82B2-41B3-9D85-7B5823A35500Q37525423-568D4867-53CB-44AD-97A5-9E7ECBE1D147Q37652060-6DF812D6-C62D-48FC-9C5A-028EB1C9A4C8Q37687254-B786CF7E-4071-4016-AC81-C144DFD0B6F4Q37824013-BA9F2CB3-8982-4BD9-942A-713458576271Q37830008-A3C57B81-6638-4C3B-AD43-A0BF7DD4889BQ38052115-712E83DB-9E10-4AB9-A5E5-CABD9429DFC7Q38444747-5DD3DD5D-5CA8-41E8-903B-0F7FE7E7D85FQ38451324-A88E1544-B6A9-450F-8341-02ECAB653035Q38457820-ECD7618C-7CF3-45BA-8574-A061F4DC4DCEQ38460526-80F11B2D-F4B9-447C-B8D8-F582D324A726Q38787619-7457D475-BF21-42B2-9A0B-8F30B64DEF60Q38868828-F3AB7018-997B-436D-A65A-1074E4C6F1AEQ38875042-36166061-9EFB-4DFD-9AD7-FDD514980710Q39003327-72A3AFCC-2073-4E14-BD90-575968445866Q39215913-CD3324ED-7C0B-4C08-9A6B-AE0A9E5FC878Q39247645-3F30FE01-F591-4968-A4D8-C3A4F45B444BQ39958992-9507CFB3-C6E0-4324-8A31-0A476B3A4246Q44674655-4DB62473-6157-4655-BE69-36DF2F313BDBQ46762045-FC13C658-284D-4F3E-94DA-BDECEA0205ECQ46816356-FB6CC9E0-ACB3-45E6-957D-DBA9BFB41CFCQ47211149-5C6CFFFB-81C8-4FBC-AD43-DAD6161704BFQ47392733-57EFB332-F7E5-471D-B66C-B3B334F36D71Q48208419-99E61EDA-7D4C-476E-A307-4BD6FD0BC9F6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Petretto
@ast
Andrea Petretto
@en
Andrea Petretto
@es
Andrea Petretto
@nl
Andrea Petretto
@sl
type
label
Andrea Petretto
@ast
Andrea Petretto
@en
Andrea Petretto
@es
Andrea Petretto
@nl
Andrea Petretto
@sl
prefLabel
Andrea Petretto
@ast
Andrea Petretto
@en
Andrea Petretto
@es
Andrea Petretto
@nl
Andrea Petretto
@sl
P106
P1153
14424424500
P31
P496
0000-0001-7811-8517